Clinical Report: VCTE vs. histology in MASLD

Overview

Vibration-controlled transient elastography (VCTE) demonstrates prognostic accuracy comparable to liver biopsy for predicting liver-related events in metabolic dysfunction-associated steatotic liver disease (MASLD). A multi-center study involving 3,532 adults showed nearly identical performance between VCTE-derived liver stiffness measurement (LSM) and histology.

Background

The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) necessitates effective prognostic tools for liver-related outcomes. Traditional liver biopsy, while accurate, is invasive and carries risks. Noninvasive methods like VCTE offer a promising alternative for risk stratification and monitoring in MASLD patients.

Data Highlights

Key Findings

• VCTE-derived LSM and liver biopsy showed comparable prognostic performance for predicting liver-related events (LREs).
• Five-year AUROC values were nearly identical: 0.870 for LSM and 0.869 for histology.
• During a median follow-up of 56.6 months, 3.6% of patients developed LREs, primarily due to hepatic decompensation.
• Results were consistent across secondary outcomes and sensitivity analyses.
• LSM may serve as a practical alternative to histology in clinical trials and risk stratification.

Clinical Implications

The findings support the use of VCTE as a noninvasive tool for assessing liver stiffness in patients with MASLD, potentially reducing the need for liver biopsy. Clinicians may consider incorporating LSM into routine practice for monitoring liver health and guiding treatment decisions.

Conclusion

VCTE offers a reliable noninvasive alternative to liver biopsy for predicting clinically meaningful liver outcomes in MASLD, enhancing patient management strategies.

References

1. Castéra L, et al., Hepatology, 2025 -- Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver disease
2. Journal of Gastroenterology — Intracellular Organelle Abnormalities in Metabolic Dysfunction-Associated Steatotic Liver Disease
3. European Radiology — Imaging Characteristics of Newly Recognized Low-Grade Vascular Tumors in the Liver: Hepatic Small Vessel Neoplasm and Anastomosing Hemangioma
4. Acta Neuropathologica — Comparative Analysis of T Cell Cytotoxicity and Mechanisms of Cell Death in Progressive Multifocal Leukoencephalopathy, Herpes Simplex Virus Encephalitis, and Cytomegalovirus Encephalitis
5. the pathologist — Virtual Staining in the Tumor Microenvironment
6. Noninvasive Liver Disease Assessment | AASLD
7. Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver disease - PubMed
8. Hepatology